GB9600888D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB9600888D0
GB9600888D0 GBGB9600888.3A GB9600888A GB9600888D0 GB 9600888 D0 GB9600888 D0 GB 9600888D0 GB 9600888 A GB9600888 A GB 9600888A GB 9600888 D0 GB9600888 D0 GB 9600888D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9600888.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to GBGB9600888.3A priority Critical patent/GB9600888D0/en
Publication of GB9600888D0 publication Critical patent/GB9600888D0/en
Priority to AU73220/96A priority patent/AU7322096A/en
Priority to CA002242716A priority patent/CA2242716A1/en
Priority to EP96935143A priority patent/EP0874633A1/en
Priority to PCT/GB1996/002673 priority patent/WO1997025991A1/en
Priority to JP9525759A priority patent/JP2000501108A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GBGB9600888.3A 1996-01-17 1996-01-17 Method of treatment Pending GB9600888D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9600888.3A GB9600888D0 (en) 1996-01-17 1996-01-17 Method of treatment
AU73220/96A AU7322096A (en) 1996-01-17 1996-10-31 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dih ydro-7h-pyrido{3,2,1,ij}-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial
CA002242716A CA2242716A1 (en) 1996-01-17 1996-10-31 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial
EP96935143A EP0874633A1 (en) 1996-01-17 1996-10-31 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial
PCT/GB1996/002673 WO1997025991A1 (en) 1996-01-17 1996-10-31 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial
JP9525759A JP2000501108A (en) 1996-01-17 1996-10-31 (9-Fluoro-3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-2,3-dihydro-7H-pyrido [3,2,1, IJ] -1,3,4- Esters of benzoxadiazine-6-carboxylic acid) and their use as antibacterial agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600888.3A GB9600888D0 (en) 1996-01-17 1996-01-17 Method of treatment

Publications (1)

Publication Number Publication Date
GB9600888D0 true GB9600888D0 (en) 1996-03-20

Family

ID=10787124

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9600888.3A Pending GB9600888D0 (en) 1996-01-17 1996-01-17 Method of treatment

Country Status (5)

Country Link
EP (1) EP0874633A1 (en)
JP (1) JP2000501108A (en)
AU (1) AU7322096A (en)
GB (1) GB9600888D0 (en)
WO (1) WO1997025991A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0259804B1 (en) * 1986-09-12 1993-11-18 F. Hoffmann-La Roche Ag Pyrido[3,2,1-ij]-1,3,4-benzoxadiazine derivatives, process for their preparation, resulting pharmaceutical preparations and intermediates for use in the process

Also Published As

Publication number Publication date
AU7322096A (en) 1997-08-11
WO1997025991A1 (en) 1997-07-24
JP2000501108A (en) 2000-02-02
EP0874633A1 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
ZA977564B (en) Method of treatment
GB9715295D0 (en) Novel method of treatment
GB9712866D0 (en) Novel method of treatment
EP0933803A4 (en) Method of plasma treatment
GB9605828D0 (en) Treatment method
GB9707693D0 (en) Novel method of treatment
GB9715298D0 (en) Novel method of treatment
GB9715306D0 (en) Novel method of treatment
GB9618341D0 (en) Method of treatment
ZA973988B (en) Method of treatment
GB9507825D0 (en) Method of treatment
PL345261A1 (en) Method of treatment
GB9415902D0 (en) Method of treatment
GB9407335D0 (en) Method of treatment
GB9414652D0 (en) Method of treatment
GB9600888D0 (en) Method of treatment
GB9602404D0 (en) Methods of treatment
GB9822681D0 (en) Method of treatment
EG24199A (en) Novel method of treatment
EG24157A (en) Novel method of treatment
GB9717399D0 (en) Method of treatment
GB9724289D0 (en) Method of treatment
GB9420524D0 (en) Method of treatment
GB9712865D0 (en) Novel method of treatment
GB9523655D0 (en) Method of treatment